The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Vol.
33
No.
10
March 16, 2007Mar 16, 2007
Free
DOWNLOAD THE PDF

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

Amgen Says It Can Demonstrate Safety of Existing Hg Target.

If You Were On ODAC: Experts Suggest Questions For May 10 Advisory Meeting.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account